Supernus Pharmaceuticals Inc. (SUPN) Financial Statements (2024 and earlier)

Company Profile

Business Address 9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments339,680422,533347,073356,018140,04090,121
Cash and cash equivalents203,434288,640181,381192,248100,30466,398
Short-term investments136,246133,893165,692163,77039,73623,723
Receivables148,932140,87787,332102,92265,58641,527
Inventory, net of allowances, customer advances and progress billings85,95948,32526,62825,65916,30416,801
Inventory85,95948,32526,62825,65916,30416,801
Other undisclosed current assets27,01918,68211,6118,8886,5212,955
Total current assets:601,590630,417472,644493,487228,451151,404
Noncurrent Assets
Operating lease, right-of-use asset   21,279
Property, plant and equipment  37,82417,0684,0955,1244,344
Long-term investments and receivables119,166350,359591,773418,798133,63875,410
Long-term investments119,166350,359591,773418,798133,63875,410
Intangible assets, net (including goodwill)902,209442,25324,84031,36836,01916,490
Goodwill117,51677,911    
Intangible assets, net (excluding goodwill)784,693364,34224,84031,36836,01916,490
Deferred costs      19,860
Deferred income tax assets   32,063
Other noncurrent assets49,23243,249615380389331
Deferred tax assets, net29,68320,84341,729
Other undisclosed noncurrent assets16,955     
Total noncurrent assets:1,087,562873,685687,638484,324196,013158,164
TOTAL ASSETS:1,689,1521,504,1021,160,282977,811424,464309,568
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities117,68378,93449,71452,10750,08735,489
Taxes payable  2,44312,37715,938 
Accounts payable   10,1413,1956,8448,055
Accrued liabilities117,68378,93437,13036,53527,30527,434
Debt 3,7612,825   
Business combination, contingent consideration, liability44,84030,900    
Other liabilities20,1329,082    
Other undisclosed current liabilities132,724122,431108,048109,24672,91345,253
Total current liabilities:315,379245,108160,587161,353123,00080,742
Noncurrent Liabilities
Long-term debt and lease obligation 420,550390,330375,610329,462 4,165
Long-term debt, excluding current maturities 379,252361,751345,170329,462 4,165
Liabilities, other than long-term debt137,372123,8069,40911,39810,5774,116
Deferred income tax liabilities85,35535,215 
Other liabilities16,38042,7919,40911,39810,5774,002
Operating lease, liability41,29828,57930,440
Business combination, contingent consideration, liability35,63745,800    
Derivative instruments and hedges, liabilities      114
Other undisclosed noncurrent liabilities   19,24822,57523,40728,790
Total noncurrent liabilities:557,922514,136404,267363,43533,98437,071
Total liabilities:873,301759,244564,854524,788156,984117,813
Equity
Equity, attributable to parent815,851744,858595,428453,023267,480191,755
Common stock535353525150
Additional paid in capital434,337409,332388,410369,637294,999276,127
Accumulated other comprehensive income (loss)1,5398,9757,417(3,158)(747)(134)
Retained earnings (accumulated deficit)379,922326,498199,54886,492(26,823)(84,288)
Total equity:815,851744,858595,428453,023267,480191,755
TOTAL LIABILITIES AND EQUITY:1,689,1521,504,1021,160,282977,811424,464309,568

Income Statement (P&L) ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues579,775520,397392,755408,897302,238215,003
Revenue, net294,097210,078
Cost of revenue(95,920)(65,761)(16,660)(15,356)(15,215)(11,986)
Cost of goods and services sold(75,061)(52,459)(16,660)(15,356)(15,215)(11,986)
Gross profit:483,855454,636376,095393,541287,023203,017
Operating expenses(397,826)(280,938)(227,524)(249,097)(187,482)(148,801)
Operating income:86,029173,698148,571144,44499,54154,216
Nonoperating income (expense)(12,854)(5,050)(1,084)(4,268)1,077(3,847)
Investment income, nonoperating    13,8432,9401,930
Other nonoperating income (expense)(12,854)(5,050)(1,084)  (15)
Interest and debt expense(19,696)(19,435)(18,207)(13,840)(295)(671)
Income from continuing operations before equity method investments, income taxes:53,479149,213129,280126,336100,32349,698
Other undisclosed income from continuing operations before income taxes19,69619,43518,20713,840295671
Income from continuing operations before income taxes:73,175168,648147,487140,176100,61850,369
Income tax expense (benefit)(19,751)(41,698)(34,431)(29,183)(43,334)40,852
Income from continuing operations:53,424126,950113,056110,99357,28491,221
Income before gain (loss) on sale of properties:53,424126,950113,056110,99357,28491,221
Net income attributable to parent:53,424126,950113,056110,99357,28491,221
Other undisclosed net income available to common stockholders, basic      
Net income available to common stockholders, basic:53,424126,950113,056110,99357,28491,221
Interest on convertible debt    134543
Dilutive securities, effect on basic earnings per share     32(416)
Net income available to common stockholders, diluted:53,424126,950113,056110,99357,45091,348

Comprehensive Income ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income:53,424126,950113,056110,99357,28491,221
Comprehensive income:53,424126,950113,056110,99357,28491,221
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(7,436)1,55810,575(2,411)(613)354
Comprehensive income, net of tax, attributable to parent:45,988128,508123,631108,58256,67191,575

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: